TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ATNM

Actinium Pharmaceuticals Inc

Healthcare · Biotechnology

1.20$ +0.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Actinium Pharmaceuticals Inc (ATNM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 40 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ATNM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
89 81 88 90 82 77 69 63 56 52 45 40
86 78 85 87 80 75 66 61 54 49 43 38
83 77 84 86 79 73 65 60 53 48 42 36
83 77 84 86 79 73 65 60 53 48 42 36
45 45 44 46 44 44 43 44 42 44 43 9.9
8.7 8.5 8.1 9.7 7.8 8.1 7.1 8.3 6.8 8.0 7.3 9.3
0.5 0.5 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7
8.2 8.0 7.5 9.2 7.2 7.6 6.5 7.7 6.2 – 6.6 8.5
44 36 44 44 38 33 26 19 14 7.8 2.3 30
-328 -338 -346 -358 -369 -376 -392 -399 -404 -410 -415 -387
27 28 28 30 31 31 31 31 31 31 31 31

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?